2021 Virtual Exhibitors
Gold Exhibitors
Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Learn more at www.gene.com.
As a highly specialized division for ophthalmic specialists, Sun Ophthalmics is able to anticipate needs from the professional and patient eye care community and quickly respond. With our experience and commitment to a working partnership, you and your staff can get more of what you want and need from our dedicated team. We look forward to meeting your passion with our experience and support every step of the way. stablished in 2015, Sun Ophthalmics is backed by Sun Pharma, a multinational pharmaceutical company.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.
As we build a growing pipeline and explore all potential uses for our medicines, we strive to make a powerful difference for our patients, their caregivers and physicians every day. Our drive to deliver breakthrough therapies comes from our deep understanding of the patient journey. These patients’ courage inspires us – and drives us to listen, collaborate and build communities. That’s why, at our core, we believe science and compassion must work together to transform lives.
Silver Exhibitors:
Aerie Pharmaceuticals is an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye.
We have a passion for finding new approaches for protecting or improving vision. United by VISIONaerie® Science, deep clinical insights, and a singular focus on addressing the unmet needs in ophthalmology, we see the possibilities ahead. Join us in creating the future of eye care.
Bronze Exhibitors
OMIC is the largest insurer of ophthalmologists in the United States. Formed in 1987 by a group of visionary eye doctors, our specialty-specific program is unique in our industry. Our mission is to serve the needs of members of the American Academy of Ophthalmology by providing high quality medical liability insurance products and services. OMIC strives to be a leader in the medical liability community and to promote quality ophthalmic care and patient safety.
lvantis, Inc. is a company committed to expanding patient treatment and improving outcomes through innovative minimally invasive glaucoma surgical (MIGS) solutions, the fastest growing segment of the ophthalmology market.
Eyesight is undervalued and under treated—and we believe that it is our responsibility to help change this. At Johnson & Johnson Vision, we are united in our aspiration to partner with eye care professionals and help more people around the world preserve and restore sight for life.